Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Groome, P. A.
Right arrow Articles by Tousignant, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Groome, P. A.
Right arrow Articles by Tousignant, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Content of a Decision Analysis for Treatment Choice in End-stage Renal Disease

Who Should Be consulted?

Patti A. Groome, BFA

Tom A. Hutchinson, MB

Pierre Tousignant, MD

For an illness whose treatment options lead to similar survival, quality-of-life issues determine the choice. If the patient has not yet experienced the treatments, then the information provided regarding the options plays a crucial role in the patient's choice. The authors interviewed 43 people who are intimately involved with the treatments for end-stage renal disease (ESRD) (ten physicians, 11 nurses, and 22 patients) with a view to determining what information needs to be considered when choosing between the various treatment options for this illness. They compared the three groups based on the items obtained from the interviews to deter mine whether the inclusion of patients in the process changed the content of the treatment descriptions. They were also interested in determining whether the use of the frequency with which an item is mentioned in the interviews is a valid measure of its relative importance to other items. 1,269 relevant items were obtained from the interviews and categorized into 51 areas of concern (subject domains). The health professionals (physicians and nurses) were found to have mentioned seven subject domains more often than the patients, and no domain was mentioned more often by the patients than by the health professionals. The frequency that an item was mentioned was correlated (r = 0.55) with direct measures of its importance. These results imply that careful consultation with health professionals to determine the content of a decision analysis or informational materials that address treatment choice is sufficient to address patient concerns and that items can be chosen for inclusion based on the relative frequencies with which they are mentioned. Key words: end-stage renal dis ease ; treatment choice; decision analysis; informed consent. (Med Decis Making 1994; 14:91-97)

Medical Decision Making, Vol. 14, No. 1, 91-97 (1994)
DOI: 10.1177/0272989X9401400111


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Med Decis MakingHome page
E. B. Bass, M. W. Jenckes, N. E. Fink, K. A. Cagney, A. W. Wu, J. H. Sadler, K. B. Meyer, Andrews. Levey, and N. R. Powe
Use of Focus Groups to Identify Concerns about Dialysis
Med Decis Making, August 1, 1999; 19(3): 287 - 295.
[Abstract] [PDF]